{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:38:41Z","timestamp":1792226321808,"version":"4.4.0"},"reference-count":25,"publisher":"Bentham Science Publishers Ltd.","issue":"2","funder":[{"DOI":"10.13039\/100005977","name":"Kaiser Permanente Northern California (KPNC), 2016","doi-asserted-by":"publisher","award":["CR-CN-15-2416-H_CB"],"award-info":[{"award-number":["CR-CN-15-2416-H_CB"]}],"id":[{"id":"10.13039\/100005977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDRR"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>This study aimed to compare the incidence of dementia and all-cause mortality\nup to 20 years post-treatment in an index non-demented cohort between antipsychotic (AP)\nmedication treatment and non-AP treatment groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method:<\/jats:title>\n                    <jats:p>All patients in Kaiser Permanente Northern California with a major psychiatric diagnosis\nbetween 01\/01\/1996 and 12\/31\/2000, age \u2265 50 years, and without dementia diagnosis were\nincluded. The study cohort was divided into a \u201cuser group\u201d, patients treated with AP for \u2265 365\ndays (n = 1,829), and a \u201cnon-user group\u201d, propensity score-matched on age, sex, and race (n =\n9,145). The association between AP exposure and dementia or mortality during the follow-up period\n(01\/01\/2001\u201312\/31\/2015) was evaluated using Cox proportional hazard models adjusted for\npsychiatric diagnosis, comorbidities, and other medications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result:<\/jats:title>\n                    <jats:p>The user group had a hazard ratio (HR) of 2.2 (CI 1.8\u20132.7) for dementia and 1.3 (CI 1.2-\n1.5) for death. The onset of dementia in the user group was significantly higher in patients aged \u2264\n65 years (p &lt; 0.001). The user group was sub-grouped into atypical, typical, and both; HR for\ndementia was 1.7 (CI 1.2-2.4), 2.5 (CI 1.9-3.1), and 1.8 (CI 1.4\u20132.4), respectively. Dementia and\nmortality were significantly higher in patients concurrently treated with benzodiazepine (HR 1.3;\nCI 1.2-1.5 and HR 1.4; CI 1.3\u20131.5) or tricyclic antidepressants (HR 1.2; CI 1.1\u20131.4 and HR 1.1; CI\n1.0-1.2), respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Our preliminary results reveal an association between AP treatment and increased\nrates of both dementia and mortality. Future research is needed to substantiate our current findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/2589977514666220301102717","type":"journal-article","created":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T02:15:50Z","timestamp":1646187350000},"page":"139-147","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Antipsychotic Medication Risk of Dementia and Death: A Propensity Matched Cohort Study"],"prefix":"10.2174","volume":"14","author":[{"given":"Xiu R.","family":"Lowe","sequence":"first","affiliation":[{"name":"Department of Mental Health and Addiction Medicine, Kaiser Permanente Northern California, Union City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maqdooda","family":"Merchant","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel A.","family":"Whitmer","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA"},{"name":"Department of Public Health Sciences, UC Davis, Davis, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"33","volume":"5","author":"Tr\u00e9meau F.","year":"2006","unstructured":"Tr\u00e9meau F.; Citrome L.; Antipsychotics for patients without psychosis? Curr Psychiatr 2006,5,33-44","journal-title":"Curr Psychiatr"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/j.1039-8562.2004.02099.x","volume":"12","author":"Botvinik L.","year":"2004","unstructured":"Botvinik L.; Ng C.; Schweitzer I.; Audit of antipsychotic prescribing in a private psychiatric hospital. Australas Psychiatry 2004,12(3),227-233","journal-title":"Australas Psychiatry"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1001\/archinte.166.9.1021","volume":"166","author":"Radley D.C.","year":"2006","unstructured":"Radley D.C.; Finkelstein S.N.; Stafford R.S.; Off-label prescribing among office-based physicians. Arch Intern Med 2006,166(9),1021-1026","journal-title":"Arch Intern Med"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/nn.2572","volume":"13","author":"Tost H.","year":"2010","unstructured":"Tost H.; Braus D.F.; Hakimi S.; Acute D2 receptor blockade induces rapid, reversible remodeling in human cortical-striatal circuits. Nat Neurosci 2010,13(8),920-922","journal-title":"Nat Neurosci"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1017\/S0033291710002163","volume":"41","author":"Schaufelberger M.S.","year":"2011","unstructured":"Schaufelberger M.S.; Lappin J.M.; Duran F.L.; Lack of progression of brain abnormalities in first-episode psychosis: a longitudinal magnetic resonance imaging study. Psychol Med 2011,41(8),1677-1689","journal-title":"Psychol Med"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1001\/archpsyc.64.6.633","volume":"64","author":"Keefe R.S.","year":"2007","unstructured":"Keefe R.S.; Bilder R.M.; Davis S.M.; Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Arch Gen Psychiatry 2007,64(6),633-647","journal-title":"Arch Gen Psychiatry"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"247486","DOI":"10.1155\/2013\/247486","volume":"2013","author":"Murray-Thomas T.","year":"2013","unstructured":"Murray-Thomas T.; Jones M.E.; Patel D.; Risk of mortality (including sudden cardiac death) and major cardiovascular events in atypical and typical antipsychotic users: a study with the general practice research database. Cardiovasc Psychiatry Neurol 2013,2013,247486","journal-title":"Cardiovasc Psychiatry Neurol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1017\/S0033291705006756","volume":"36","author":"Harris M.S.","year":"2006","unstructured":"Harris M.S.; Reilly J.L.; Keshavan M.S.; Sweeney J.A.; Longitudinal studies of antisaccades in antipsychotic-naive first-episode schizophrenia. Psychol Med 2006,36(4),485-494","journal-title":"Psychol Med"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1586\/ern.09.143","volume":"10","author":"Hill S.K.","year":"2010","unstructured":"Hill S.K.; Bishop J.R.; Palumbo D.; Sweeney J.A.; Effect of second-generation antipsychotics on cognition: current issues and future challeng-es. Expert Rev Neurother 2010,10(1),43-57","journal-title":"Expert Rev Neurother"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/j.1365-2524.2010.00982.x","volume":"19","author":"Leung K.K.","year":"2011","unstructured":"Leung K.K.; Finlay J.; Silvius J.L.; Pathways to diagnosis: exploring the experiences of problem recognition and obtaining a dementia diagnosis among Anglo-Canadians. Health Soc Care Community 2011,19(4),372-381","journal-title":"Health Soc Care Community"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1097\/HJH.0000000000001698","volume":"36","author":"Wang A.","year":"2018","unstructured":"Wang A.; Zhang Y.; Li J.; High SBP trajectories are associated with risk of all-cause death in general Chinese population. J Hypertens 2018,36(6),1299-1305","journal-title":"J Hypertens"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/ceo.13375","volume":"47","author":"Landers J.","year":"2019","unstructured":"Landers J.; Liu E.; Estevez J.; Henderson T.; Craig J.E.; Presence of diabetic retinopathy is associated with worse 10-year mortality among Indigenous Australians in Central Australia: The Central Australian ocular health study. Clin Exp Ophthalmol 2019,47(2),226-232","journal-title":"Clin Exp Ophthalmol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1001\/jamapsychiatry.2018.0190","volume":"75","author":"Siegmann E.M.","year":"2018","unstructured":"Siegmann E.M.; M\u00fcller H.H.O.; Luecke C.; Philipsen A.; Kornhuber J.; Gr\u00f6mer T.W.; Association of depression and anxiety disorders with autoimmune thyroiditis: A systematic review and meta-analysis. JAMA Psychiatry 2018,75(6),577-584","journal-title":"JAMA Psychiatry"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ajp.2012.08.003","volume":"6","author":"Krishna V.N.","year":"2013","unstructured":"Krishna V.N.; Thunga R.; Unnikrishnan B.; Association between bipolar affective disorder and thyroid dysfunction. Asian J Psychiatr 2013,6(1),42-45","journal-title":"Asian J Psychiatr"},{"key":"ref=15","first-page":"S95","volume":"24","author":"Nandra K.S.","year":"2012","unstructured":"Nandra K.S.; Agius M.; The differences between typical and atypical antipsychotics: the effects on neurogenesis. Psychiatr Danub 2012,24(Suppl. 1),S95-S99","journal-title":"Psychiatr Danub"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/jhbs.10152","volume":"39","author":"Heinrichs R.W.","year":"2003","unstructured":"Heinrichs R.W.; Historical origins of schizophrenia: two early madmen and their illness. J Hist Behav Sci 2003,39(4),349-363","journal-title":"J Hist Behav Sci"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1001\/jamapsychiatry.2015.1546","volume":"72","author":"Ribe A.R.","year":"2015","unstructured":"Ribe A.R.; Laursen T.M.; Charles M.; Long-term risk of dementia in persons with schizophrenia: A Danish population-based cohort study. JAMA Psychiatry 2015,72(11),1095-1101","journal-title":"JAMA Psychiatry"},{"key":"ref=18","unstructured":"U.S. Food and Drug Administration. Center for Drug Evaluation\nand Research. FDA public health advisory: deaths with antipsychotics\nin elderly patients with behavioral disturbances. 2005.\nAvailable from:  Accessed on April 11, 2005"},{"key":"ref=19","first-page":"E2","author":"Ray A.W.","year":"2018","unstructured":"Ray A.W.; Stein C.M.; Murray K.T.; Association of antipsychotic treatment with risk of unexpected death among children and youths. JAMA Psychiatry 2018,E2-E10","journal-title":"JAMA Psychiatry"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","volume":"175","author":"Gray S.L.","year":"2015","unstructured":"Gray S.L.; Anderson M.L.; Dublin S.; Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med 2015,175(3),401-407","journal-title":"JAMA Intern Med"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"k1315","DOI":"10.1136\/bmj.k1315","volume":"361","author":"Richardson K.","year":"2018","unstructured":"Richardson K.; Fox C.; Maidment I.; Anticholinergic drugs and risk of dementia: case-control study. BMJ 2018,361,k1315","journal-title":"BMJ"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/ana.21509","volume":"64","author":"Amieva H.","year":"2008","unstructured":"Amieva H.; Le Goff M.; Millet X.; Prodromal Alzheimer\u2019s disease: successive emergence of the clinical symptoms. Ann Neurol 2008,64(5),492-498","journal-title":"Ann Neurol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jagp.2019.01.215","volume":"27","author":"Creese B.","year":"2019","unstructured":"Creese B.; Brooker H.; Ismail Z.; Mild behavioral impairment as a marker of cognitive decline in cognitively normal older adults. Am J Geriatr Psychiatry 2019,27(8),823-834","journal-title":"Am J Geriatr Psychiatry"},{"key":"ref=24","author":"Scharre D.W.","year":"2019","unstructured":"Scharre D.W.;  Preclinical, prodromal, and dementia stages of Alzheimer\u2019s disease 2019","journal-title":"Preclinical, prodromal, and dementia stages of Alzheimer\u2019s disease"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"341-50","DOI":"10.1002\/gps.3826","volume":"28","author":"Vilalta-Franch J","year":"2013","unstructured":"Vilalta-Franch J; L\u00f3pez-Pousa S; Llin\u00e0s-Regl\u00e0 J; Calv\u00f3-Perxas L; Merino-Aguado J; Garre-Olmo J.; Depression subtypes and 5-year\nrisk of dementia and Alzheimer disease in patients aged 70 years. Int J Geriatr Psychiatry 2013,28(4),341-50","journal-title":"Int J Geriatr Psychiatry"}],"container-title":["Current Drug Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/2589977514666220301102717","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/201514\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/2589977514666220301102717","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T13:04:36Z","timestamp":1659445476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/201514\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/2589977514666220301102717","relation":{},"ISSN":["2589-9775"],"issn-type":[{"value":"2589-9775","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-08-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}